Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 01, 2017 07:00 ET | Source: Curis, Inc.

Curis Announces Upcoming Presentation at the American Society of Hematology 59th Annual Meeting & Exposition

LEXINGTON, Mass., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for...
November 07, 2017 07:00 ET | Source: Curis, Inc.

Curis Reports Third Quarter 2017 Financial Results

LEXINGTON, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates...
November 03, 2017 07:00 ET | Source: Curis, Inc.

Curis to Present at the Society for Immunotherapy of Cancer 32nd Annual Meeting and the Cowen IO NEXT Summit

LEXINGTON, Mass., Nov. 03, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for...
November 01, 2017 07:00 ET | Source: Curis, Inc.

Curis to Release Third Quarter 2017 Financial Results and Hold Conference Call on November 7, 2017

LEXINGTON, Mass., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the...
September 22, 2017 11:54 ET | Source: Curis, Inc

Curis to Present at the Cantor Fitzgerald Global Healthcare Conference

LEXINGTON, Mass., Sept. 22, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for...